More stories

  • in

    Rent the Runway CEO sees inflation as a competitive advantage for the company

    Rent the Runway on Wednesday reported fiscal fourth-quarter revenue ahead of analysts’ estimates along with a narrower-than-expected loss.
    According to Chief Executive Jennifer Hyman, Rent the Runway is reaping the benefits of consumers seeking value and stability during times of inflation.
    “We’re entering into one of the strongest environments for rental we’ve ever seen,” the CEO told CNBC. “The inflationary environment is basically a competitive advantage for Rent the Runway.”

    Jennifer Hyman, CEO and co-founder, Rent the Runway
    Scott Mlyn | CNBC

    Rent the Runway sees the more than 2 million weddings planned for this year, and all the parties that come with them, as being a massive boon to its business.
    Plus, according to co-founder and Chief Executive Jennifer Hyman, Rent the Runway is reaping the benefits of consumers seeking value and stability during times of inflation — with Americans seeing higher gas prices, bigger grocery bills and even more expensive price tags on their favorite clothing brands.

    To be sure, Rent the Runway is also planning price increases for its membership plans that will take effect in early May, to combat its own higher expenses.
    “We’re entering into one of the strongest environments for rental we’ve ever seen,” Hyman said in a Zoom interview. “The inflationary environment is basically a competitive advantage for Rent the Runway.”
    On Wednesday, the fashion rental platform reported fiscal fourth-quarter revenue ahead of analysts’ estimates along with a narrower-than-expected loss, as the company won over consumers looking to refresh their wardrobes to adapt to hybrid work schedules and prepare for spring and summer social events.
    Shares fell nearly 4% after previously rising about 10% in after-hours trading. The stock has fallen about 31% year to date, bringing Rent the Runway’s valuation to $360 million.
    Hyman said Rent the Runway’s business correlates closely with how much consumers are spending on experiences, rather than things. So as people are traveling more, taking Uber rides around town and booking reservations at restaurants, Rent the Runway sees an uptick in users, she said.

    Rent the Runway members pay monthly fees ranging from $94 to $235, to receive between four and 16 different items of designer clothing or accessories. Users can tack on additional items to their plans for an extra charge. They can also make one-time rentals for periods of four to eight days. And Rent the Runway gives customers the option to buy items on its website at a discount to full sticker price.
    The retailer reported a net loss for the three-month period ended Jan. 31 of $39.3 million, or 62 cents a share, compared with a loss of $38.8 million, or 70 cents per share, a year earlier. That came in narrower than analysts’ estimates for a per-share loss of 70 cents, according to a Refinitiv poll.
    Revenue grew about 91% to $64.1 million from $33.5 million a year earlier, topping estimates for $63.2 million.
    The company’s fourth-quarter gross margin of 36.7% also came in way ahead of expectations for 27.3%, based on a separate survey by StreetAccount.
    Rent the Runway ended the fourth quarter with 115,240 active subscribers, up 110% from year-ago levels. It counted 159,544 total subscribers, including those who have their accounts on pause.
    “Fifty percent of our traffic comes to Rent the Runway because [those people] have an upcoming event, or they have an upcoming occasion,” said Hyman. She added the company views this moment in time, coming out of the pandemic, as an “extremely unique window” to acquire new customers and keep them in the business longer term.
    To cater to people searching for wedding dresses, for example, Rent the Runway has launched its own wedding concierge service. In its recent marketing, the company is positioning itself as a “value oriented way to get dressed for multiple events,” Hyman said.
    For the first quarter of fiscal 2022, Rent the Runway expects sales to be between $63.5 million and $64.5 million, with active subscribers totaling 130,000 to 132,000. Analysts were looking for revenue of $64.3 million, according to Refinitiv.
    For the year, the company projects revenue to be in a range of $295 million to $305 million, compared with sales of $203.3 million in fiscal 2021. Analysts had forecast revenue to be $305 million.
    Hyman emphasized that, in addition to winning new customers, the company is prioritizing reaching profitability, though the exact timing on that mark remains unclear.
    “Profitability is our number one goal,” she said. “And it’s my number one priority as the CEO.”
    Find the full financial press release from Rent the Runway here.

    WATCH LIVEWATCH IN THE APP More

  • in

    Stocks making the biggest moves midday: JPMorgan, Delta Air Lines, PayPal

    The JP Morgan Chase & Co. headquarters, The JP Morgan Chase Tower in Park Avenue, Midtown, Manhattan, New York.
    Tim Clayton – Corbis | Corbis Sport | Getty Images

    Check out the companies making headlines in midday trading.
    JPMorgan Chase – Shares fell 3.2% as JPMorgan Chase reported a $524 million hit from market dislocations caused by sanctions against Russia due to the war in Ukraine. The bank posted better-than-expected earnings and revenue in the first quarter, but profit fell 42% from the year prior.

    Delta Air Lines — The airline stock rose 6.2% as Delta forecast a return to profit in the current quarter. Delta posted a narrower-than-expected loss per share in its fiscal first quarter and beat consensus revenue expectations.
    American Airlines — Other travel stocks jumped after Delta’s report. American Airlines soared 10.6%, Southwest Airlines jumped 7.5%, and Norwegian Cruise Line added 6.2%.
    PayPal Holdings, Walmart – Walmart on Tuesday after the bell announced it hired PayPal chief financial officer John Rainey. Rainey will replace Brett Biggs, who was CFO since 2015. PayPal fell about 2.9%, while Walmart shares rose 2.6%.
    Fastenal – Shares rose 2.2% after a stronger-than-expected quarterly earnings report. The company reported profit of 47 cents per share on revenue of $1.7 billion. Analysts surveyed by Refinitiv expected a profit of 45 cents per share on revenue of $1.69 billion.
    Charles Schwab – The brokerage company advanced 4.7% after Morgan Stanley named it a “top pick” and said rising rates will boost the stock. The firm’s price target on BlackRock implies upside of about 65%.

    Warner Bros. Discovery – Shares rose 5.4% after Bank of America initiated the media stock with a buy rating. The firm said the merger of the two media companies creates a “powerhouse.”
    Gap – The retail stock surged 8.2% after a report from Activist Insight speculating the company could be a potential activist target. CNBC has not confirmed the report.
    — CNBC’s Samantha Subin and Tanaya Macheel contributed reporting.

    WATCH LIVEWATCH IN THE APP More

  • in

    Uninsured face surprise medical bills for Covid testing, hospital treatment after U.S. Congress fails to fund pandemic aid program

    The federal government has stopped covering the cost of Covid testing, treatment and vaccination for the uninsured due to insufficient funds.
    The $10 billion Senate Covid funding deal does not include money for the uninsured.
    Quest Diagnostics, Labcorp and Curative are now charging the uninsured more than $100 for Covid tests in some instances. Walgreens and CVS still offer free services.
    Some hospitals may also start charging uninsured people who need treatment for Covid.
    The uninsured could also face reduced access to vaccination if pharmacies start pulling out of the federal program due to administrative costs.

    Secretary of Health and Human Services Xavier Becerra testifies before the Senate Health, Education, Labor, and Pensions Committee hearing to discuss reopening schools during the coronavirus disease (COVID-19) at Capitol Hill in Washington, D.C., September 30, 2021.
    Shawn Thew | Pool | Reuters

    People who don’t have health insurance are now being charged $100 or more for Covid testing by some labs and may face bills for hospital treatment, and free vaccines may not be as easy for everyone to get since emergency federal aid for some pandemic programs has run out and hasn’t been renewed by Congress.
    Senators reached a $10 billion bipartisan Covid funding deal last week. However, the package does not include the White House’s $1.5 billion request for a program that covers testing and treatment for the uninsured as well as some vaccine costs that is administered by the Health and Human Services Department, according to summaries of the deal released by the offices of Senate Majority Leader Chuck Schumer, D-N.Y., and Sen. Mitt Romney, R-Utah.

    Funding for the uninsured was dropped by Senate and House negotiators after Republicans opposed the money needed to extend the program, a senior Democratic aide in the U.S. House told CNBC. Emails to House and Senate GOP leaders weren’t immediately returned.
    The current Senate package would fund additional supplies of vaccines, monoclonal antibody treatments, antiviral pills as well as research for the next generation of shots. Congress left Washington last Thursday for a two-week recess without passing the deal, so it’s not clear when a vote might be held. Republicans blocked the bill from advancing over the Biden administration’s decision to end a CDC policy that deported migrants crossing U.S. land borders as a pandemic emergency measure.
    The $10 billion Senate deal is less than half the $22.5 billion originally requested by President Joe Biden, and it still needs to clear each chamber before it can be sent to Biden for his approval. It’s not clear how the deal would fare in the House if the Senate does manage to pass it, or if there’s any flexibility for some of the $10 billion to be shifted to help the uninsured.
    Meanwhile, the Health Resources and Services Administration, which runs the uninsured program for HHS, stopped accepting claims to test and treat uninsured Covid patients on March 22 due to insufficient funds. While the U.S. is providing Covid shots for free, the agency stopped covering the costs to administer the vaccines for uninsured people as of April 5, shortly after the FDA cleared second booster shots for people 50 and over.
    “All those doctors, hospitals, pharmacists, nursing homes, community health centers that were relying on the provider relief fund that Congress enacted to help reimburse them for some of the Covid related costs — those have now been stopped,” Health and Human Services Secretary Xavier Becerra said last week. “The claims no longer are being accepted as of this week for even vaccines.”

    Several major testing companies are now charging the uninsured. Quest Diagnostics told CNBC uninsured people now have to pay at least $100 for a PCR test, which is the most accurate one. Labcorp told CNBC the company is charging $119 for its at-home or in-person PCR testing for people who aren’t covered by insurance. Curative, which runs thousands of testing sites across 34 states, said it can no longer provide free Covid testing to the uninsured in areas of the country where state or local governments aren’t picking up the tab. The company said it is piloting a program where the uninsured can pay $99 to $135 cash for tests, depending on the type of product at select sites.
    “We are deeply concerned about this recent development regarding federal funding and the impact it will have on uninsured patients. We ask that funding be re-instituted to ensure that uninsured patients have access to no out-of-pocket testing,” a spokesperson for Curative said.
    CVS and Walgreens are still providing testing, antiviral pills and vaccines to the uninsured for free, the companies told CNBC. CVS spokesman Mike DeAngelis said the company is confident the White House and Congress will find a solution giving the uninsured free access to Covid services. Walgreens spokeswoman Alex Brown said the company is waiting further guidance from the White House once a Covid funding deal is actually passed.

    CNBC Health & Science

    Read CNBC’s latest global coverage of the Covid pandemic:

    Without additional federal money, people in the U.S. will face a dramatic reduction in access to testing, particularly the uninsured, that will likely result in Covid outbreaks that were preventable, according to Dr. Georges Benjamin, executive director of the American Public Health Association.
    “You’re going to have people just as we had in the first part of the pandemic having to hunt for testing,” Benjamin said. “It’s a disaster waiting to happen, and it just prolongs this outbreak longer than it needs to.”
    Uninsured people who become hospitalized with Covid could also face bills for their treatment now that the federal government is no longer reimbursing hospitals, according to Molly Smith with the American Hospital Association. Smith said treating someone with Covid can cost anywhere from tens of thousands to hundreds of thousands of dollars if the patient ends up on a mechanical ventilator.
    Some hospitals have financial assistance plans for the uninsured, Smith said. However, there is growing concern that some patients simply won’t go the hospital when they need treatment for Covid because they’re worried about how much it will now cost.
    “We know that people’s fear about the cost of care is a significant barrier that already exists,” said Smith, the AHA’s vice president for policy. “Our biggest fear is people just avoiding avoiding care at all.”
    The uninsured could also face reduced access to vaccines. Health-care providers sign agreements with the Centers for Disease Control and Prevention in which they are required to offer vaccines to patients free of charge regardless of their insurance status. The federal government has been covering the costs for the shots as well as the administrative expenses incurred by the companies like CVS and Walgreens that administer the shots. Without the $1.5 billion, companies will be on the hook to cover those extra fees on their own.
    The CDC has told pharmacies they are still required to offer the shots at no cost if they participate in the federal vaccination program. However, the agreements are voluntary, which means pharmacies can pull out of the program at any time, and the CDC can also kick out providers who don’t follow the rules.
    That means pharmacies could leave of the federal vaccination program if they are unable to shoulder the administrative costs. Pharmacies have administered about 42% of Covid vaccinations in the U.S., according to data from the CDC.
    More than two dozen pharmacy associations wrote House Speaker Nancy Pelosi, D-Calif., and Minority Leader Kevin McCarthy, R-Calif., late last month calling for Congress to take immediate action to fully fund the uninsured program. They warned that failure to fund the program would jeopardize equitable access to vaccines for people who do not have health insurance.
    Smaller independent pharmacies now face a particularly difficult choice since they are already operating with razor thin margins, according Ronna Hauser, senior vice president of policy at the National Community Pharmacists Association.
    “For the vast majority of our members providing uncompensated care at this point in the pandemic is a very difficult decision to make financially and we won’t be able to do it to much extent unfortunately,” Hauser said.
    There were 28 million uninsured people in the U.S. in 2020, according to the most current data available from the Census Bureau. The current number of uninsured is likely lower due to a record 14.2 million people signing up for health insurance through the Affordable Care Act as of January this year, about 2 million more people than the previous record of 12.6 million set in 2016.
    The uninsured are often people of color and lower-income workers who have jobs that put them at higher risk of infection because they are work in industries such as retail, restaurant and grocery stores where they interact with the public and can’t stay at home, according to Jennifer Tolbert, an expert on the uninsured at the Kaiser Family Foundation.
    While Covid cases are low right now in the U.S. compared to the peak of the winter omicron wave, barriers to testing will leave these communities more vulnerable again if another wave hits the U.S., Tolbert said. Curative said its real-time data points to another potential surge on the horizon.
    “If you think about this from a public health perspective, it is just more about preparing should another surge happen so that you’re not caught off guard before you can put all of the pieces back in place to ensure that people can access the test and the treatment,” Tolbert said.
    The uninsured program, established at the start the pandemic under the Trump administration, has paid out about $20 billion in claims since 2020, according to HRSA. Tolbert said about 60% of that money went toward testing, 31% for Covid treatments, and 9% for the administrative costs of vaccinations.
    The HRSA said people without health coverage should check their eligibility for Medicaid and for plans available through the ACA at healthcare.gov. The uninsured can also order free at-home tests from the government at covidtest.gov, though households are limited to two sets of four tests.
    The uninsured can also continue to receive Covid services for free at federally-backed community health centers across the country, which can be located through the HHS website.
    “The truth is that unfortunately the uninsured are the last to be thought about and the first to get the negative outcomes when we decide to pull back,” Benjamin said.

    WATCH LIVEWATCH IN THE APP More

  • in

    Apollo's head of sustainable investing says we need to speed up the transition toward clean energy

    (Click here to subscribe to the Delivering Alpha newsletter.)
    Geopolitical tensions in Ukraine have had a massive impact on global energy supply chains and prices this year, reminding the world how reliant we are on fossil fuels and how far we are from a true shift toward clean energy. That shift will require $131 trillion in energy transition investments by 2050, according to the International Renewable Energy Agency. 

    To find out how all this capital will be deployed, Leslie Picker sat down with Apollo Global Management’s Olivia Wassenaar for the Delivering Alpha newsletter. Wassenaar helms Apollo’s sustainable investing platform and also co-leads natural resources at the firm. Her team has invested $19 billion in the energy transition and decarbonization and has committed $50 billion more over the next five years. 
     (The below has been edited for length and clarity. See above for full video.)
    Leslie Picker: Given the discussions that you’re having in and out of the boardrooms, do you think that the war in Europe has exacerbated this transition to clean energy? Or do you think it’s actually slowed it as people realize, “Wait a minute, we can’t transition this quickly without making sure that we are still able to fulfill the needs of traditional sources of energy.” 
    Olivia Wassenaar: I do think everything that’s going on has made us all realize that we do need to speed up the transition. This is something that has been at work for the last several decades and yet in many ways, it still feels like we’re at Ground Zero. When we look at the amount of capital for the next 10, 20, 30 years that needs to get invested in the energy transition, we estimate it’s about $4.5 trillion a year to get us where we need to be in the future.
    Picker: You think then that you can do both at the same time, effectively, ensure that nations especially in the U.S. and Western Europe are able to meet their short-term energy goals while also focusing on the long-term? Or do you think that the two actually get muddled given the crisis nature of the situation?

    Wassenaar: We do absolutely need to transition to cleaner fuels over time, but you’re right in that it’s something that is not going to happen overnight. And so, we look at some things that are bridge fuels. For example, something like LNG is very critical for taking lower carbon fuels to areas that are currently burning higher carbon fuels such as coal and diesel, for example. So, it is very much a transition. It is an area where we will see evolution over time and I do think it’s important to acknowledge that.
    Picker: In terms of investment, there’s a statistic that’s been thrown out there saying that the annual clean energy investment globally will need to be about $4 trillion to achieve net zero carbon emissions by 2050. That 4 trillion will need to take place probably within the next five years on an annual basis that is a lot of money going into one area. Do you think that that will come from private capital? And where else? And what role specifically does private capital play in that investment?
    Wassenaar: I think there’s a really big role for private capital to play here and that’s something that really excites me when I look at what Apollo is doing. We’ve looked at it and over the last five years we’ve invested about $19 billion into the energy transition and decarbonization. And as we look at where we think we can invest going forward, we’ve targeted $50 billion over the next five years. And that’s in all different forms of capital, that’s across the capital structure, and that’s really throughout the climate ecosystem, as we look at different ways to really invest capital and drive change here.
    Picker: What about the role of private capital in traditional sources of energy? I ask because in recent years, we’ve heard laments from LPs and others looking at the role that private capital has played in fossil fuels and high carbon emitters. And people have really shown that in recent years. And so, I’m curious if that increases your hurdle in making a new investment in some of the browner sources of energy, which, as we’ve discussed, have become increasingly more of a necessity recently, or if you were much more focused these days on clean energy instead?
    Wassenaar: One of the areas of focus for us has really been in helping traditional energy companies really achieve their own transition and their own targets here. So, for example, last year, we invested in an environmentally friendly compression company that helps oil and gas companies as they compress natural gas to emit less carbon. And for us, we view that as a quintessential investment in the transition to really, sort of help these companies be where they need to be. 
    Picker: Given the dynamic at play, and we’ve seen recently, several multibillion-dollar climate funds raised both from an infrastructure standpoint, a private equity standpoint, some private credit funds raising – I know that’s been a focus of yours as well. Given the increased intention to clean energy and clean energy-adjacent companies and investments, are you seeing a valuation differential between those types of investments versus traditional energy companies? And where do you see opportunity between the two?
    Wassenaar: I actually love seeing that there’s so much capital going to this space. As we discussed before, there is such a giant need for capital here, so this is a situation where really the more the merrier. There is just really so much to do. As I think about valuations and where we’re focused, absolutely, there are parts of the value chain in the broader ecosystem where you are seeing really high valuations. Where we’ve tried to focus at Apollo is areas where there is value and where there is also real opportunity. So, for example, for us, we have spent a lot of time looking at some of the services in and around the energy transition. So, for example, you know, rather than just investing in a wind farm, things that we have invested in are wind logistics businesses, businesses that do the operation and maintenance, so things like rotating out blades or gearbox maintenance, the staging in and around assembling a wind farm. These are the types of things that we feel are really priced right for private equity, where you can see a private equity rate of return but are also still very critical services in and around the energy transition.
    Picker: What about private debt? Are these businesses the type that they’re looking for sources of credit, alternative sources of credit at this point in time? Are they profitable enough to seek it? And to get that from you?
    Wassenaar: The answer is it depends. You know, we see some companies that just aren’t ready yet. But for the most part, we are really seeing a growing up with this business. I worked on my first solar deal back in 2008 and it’s amazing to me the difference we see in the industry between then and now. And I remember we weren’t sure if you get financing on panels, what the lifecycle was, things like that. Bankability was a really big question. As we look at where the sector is today, we’ve just seen such a massive evolution, that especially in things like wind and solar, there is absolutely the ability to finance these as well as other businesses like biofuels, bioenergy, batteries, etc. There are some businesses that are newer, that are earlier stage, that may have a technology risk component, that may not be the right recipient of debt at this point. But we are very much at Apollo having early-stage conversations with these companies to make sure that we are well set up to be a provider of capital if and when they reach the stage in their development that that’s something they’re looking to do.
    Picker: When people think of natural resources, these days, they think of inflation and it’s been one of the few areas, at least from the commodity side of things that’s seen somewhat of a tailwind from what’s going on in the macro environment. What does it mean, though, for your portfolio companies? Is the story that simple, just the fact that these companies have exposure to natural resources, their margins are going to do better? Or is it more complicated behind the scenes?
    Wassenaar: It is absolutely more complicated, and every company is a little bit different, but we do very much see the impacts of inflation really throughout our portfolio. And gosh, I was with one of my businesses last week in Texas, and just talking about the ability to get trucks, right. So, they’ve got supply chain issues and on top of that, the price of the trucks versus where they were last year, and versus what we had in the budget has gone up materially. And so, you look at this and say, this is a services business, they absolutely need to get their employees and their equipment from one destination to another. And being able to source and obtain trucks is very critical to what they do. But just the way which we think about it is so different from a year ago. 
    Picker: You’ve actually been interested in sustainability before it was cool. You’ve been interested in this area for a really long time and kind of grew up through your career in finance, studying sustainability. Can you give us a sense of how the market has really changed in this area, given your long history in looking at it?
    Wassenaar: It has changed so much, but all in a really good way…it’s been a long 15 plus years here, as you’ve seen. Some of these companies go up and down. There were some trouble years from a financing perspective but what I love today is it has very much become mainstream. When we look at our current natural resources fund at Apollo, 60% of the natural resources fund today is in energy transition and decarbonization related businesses, which is really incredible if you think about a mainstream private equity fund that targets 20% plus rates of return, not venture capital, private equity, and this is an area that we should deploy a significant amount of capital. For me, coming from early days of the World Bank and having seen the sector for so many years, it really has been a wonderful transition to witness. More

  • in

    Delta ends $200 monthly health insurance surcharge on unvaccinated employees after Covid cases drop

    Delta Air Lines this month ended its $200 monthly surcharge on unvaccinated employees’ company health insurance.
    Delta announced the policy last August to take effect November 2021.
    At the time, CEO Ed Bastian said the average hospital stay for an employee with Covid-19 cost Delta $50,000.

    A Delta Airlines passenger jet approaches to land at LAX during the outbreak of the coronavirus disease (COVID-19) in Los Angeles, California, U.S., April 7, 2021.
    Mike Blake | Reuters

    Delta Air Lines this month ended its $200 monthly surcharge on unvaccinated employees’ company health insurance, ending a pandemic policy designed to encourage staff to get inoculated against Covid-19.
    CEO Ed Bastian announced the policy shift on a Wednesday call discussing the airline’s first-quarter results and outlook.

    “We’ve dropped as of this month the additional insurance surcharge given the fact that we really do believe that the pandemic has moved to a seasonal virus,” Bastian said. “Any employees that haven’t been vaccinated will not be paying extra insurance costs going forward.”
    Delta announced the policy last August to take effect November 2021. At the time, Bastian said the average hospital stay for an employee with Covid-19 cost Delta $50,000.
    More than 95% of Delta’s 75,000-plus employees have been vaccinated, according to the company. It also began requiring all new hires to show proof of vaccination.
    United Airlines had the strictest vaccination policy of any U.S. airline, requiring staff to be vaccinated or face termination without an exemption for religious or medical reasons. Employees with an accommodation would be moved off customer service-facing roles, United said.
    More than 96% of that airline’s roughly 67,000 U.S. employees were vaccinated.
    Last month, United said it would allow unvaccinated workers who received an exemption to return to their regular jobs, citing a drop in Covid cases.

    WATCH LIVEWATCH IN THE APP More

  • in

    WHO says Covid still a global public health emergency even as deaths fall to lowest level in two years

    The World Health Organization said Covid-19 remains a global public health emergency even as Covid deaths have fallen to the lowest level since March 2020.
    WHO Director-General Tedros Adhanom Ghebreyesus said the international community needs to keep up the fight against Covid by ensuring equal access to vaccines and mediating measures.
    “It’s always easier to declare a pandemic than undeclare one,” said Dr. Didier Houssin, chairman of the WHO committee that makes recommendations on health emergencies.

    Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization (WHO), speaks during a news conference in Geneva, Switzerland, December 20, 2021.
    Denis Balibouse | Reuters

    The World Health Organization on Wednesday said Covid-19 remains a global public health emergency despite the fact that deaths from the virus have fallen to their lowest level since the early days of the pandemic.
    The world recorded more than 22,000 deaths from Covid during the week ended April 10, the lowest level since March 30, 2020, according to WHO data. The organization first declared Covid a global health emergency on Jan. 30, 2020, just over a month after the virus emerged in Wuhan, China.

    WHO Director-General Tedros Adhanom Ghebreyesus said declining Covid deaths is good news, but some countries are still experiencing a spike in cases. Tedros said a WHO committee this week unanimously agreed that Covid remains a public health emergency.
    “Far from being the time to drop our guard, this is the moment to work even harder to save lives,” Tedros said during a press briefing in Geneva. “Specifically, this means investing so that Covid-19 tools are equitably distributed, and we simultaneously strengthen health systems.”
    The WHO has called for world leaders to ensure all nations vaccinate 70% of their populations against Covid by the middle of the year. However, 75 countries have vaccinated less than 40% of their populations and 21 nations have vaccinated less than 10% of their people as of March, according to the group.

    CNBC Health & Science

    Read CNBC’s latest global coverage of the Covid pandemic:

    Every region is reporting declining cases and deaths, according to the WHO’s latest epidemiological update. The world recorded 7.3 million new infections for the week ended April 10, a 24% decrease from the previous week and the lowest level since late December when the highly contagious omicron variant was sweeping the world.
    However, the even more contagious omicron BA.2 subvariant has fueled renewed outbreaks in Europe and China, and increasingly, in the U.S. While Europe has largely emerged from its BA.2 wave, China is fighting its worst outbreak since 2020. China has placed most of Shanghai, involving about 25 million people, under lockdown.

    The U.S. reported more than 30,000 new infections on Monday, a 20% increase over the previous week, according to data from the Centers for Disease Control and Prevention. However, infections and hospitalizations are still more than 90% below the peak of the winter omicron wave in the U.S.
    “It’s always easier to declare a pandemic than undeclare one,” said Dr. Didier Houssin, chairman of the WHO’s international health regulations emergency committee. The committee makes recommendations about whether the transmission of a virus constitutes a global emergency.
    Houssin said the committee is working on criteria, including epidemiological data and the level of international assistance to contain the virus, to determine when the WHO can declare that the global health emergency is over.

    WATCH LIVEWATCH IN THE APP More

  • in

    Covid outbreaks in New York and DC infect senior officials as omicron BA.2 variant sweeps the U.S.

    BA.2 now represents of 86% of sequenced new cases, almost completely displacing the earlier version of omicron that fueled the unprecedented winter surge.
    The U.S. reported more than 30,000 new infections on Monday, a 20% increase over the previous week, according to data from the Centers for Disease Control and Prevention.
    Outbreaks in New York City and Washington, D.C., have resulted in senior government officials testing positive.
    White House chief medical advisor Dr. Anthony Fauci he doesn’t expect the U.S. to see a significant increase in hospitalizations and deaths.

    A man is given a coronavirus disease (COVID-19) test at pop-up testing site in New York, April 11, 2022.
    Brendan McDermid | Reuters

    Covid infections are rising again in the U.S. with outbreaks in New York City and Washington, D.C., resulting in senior government officials coming down with the virus as the more contagious omicron BA.2 subvariant sweeps across the country.
    BA.2 now represents of 86% of sequenced new cases, almost completely displacing the earlier version of omicron that fueled the unprecedented winter surge, according to Covid surveillance data published Tuesday by the Centers for Disease Control and Prevention. The BA.2 subvariant is anywhere from 30% to 80% more transmissible than the earlier omicron variant, BA.1, according to studies from the U.K. and Denmark.

    The U.S. reported more than 30,000 new infections on Monday, a 20% increase over the previous week, according to data from the CDC. However, infections and hospitalization are still more than 90% below the peak of the omicron surge in January.
    Though infections are rising, most counties still have low levels of Covid transmission and hospitalizations, which means people who live in those areas don’t need to wear masks indoors under CDC public health guidance. White House chief medical advisor Dr. Anthony Fauci said this week that Covid will continue to circulate in communities for the foreseeable future, and people will have to make individual decisions about the risk they’re willing to take based on their age and health status.
    “What we’re hoping happens, and I believe it will, is that you won’t see a concomitant comparable increase in severity in the sense of people requiring hospitalizations and deaths,” Fauci told the ABC program “This Week.” CDC Director Dr. Rochelle Walensky has previously said there’s a high enough level of immunity in the U.S. population from vaccines and prior infections to provide some protection against BA.2.
    The BA.2 subvariant is even more dominant in the Northeast, where it’s driving a significant outbreak. BA.2 represents 92% of new cases in the region that includes New York and New Jersey, according to the CDC data. New York City reported about 1,887 new infections a day on average as of Saturday, a 52% increase over the past two weeks, according to data from the city’s health department.

    CNBC Health & Science

    Read CNBC’s latest global coverage of the Covid pandemic:

    New York City Mayor Eric Adams tested positive for the virus on Sunday after waking up with a raspy voice. Adams attended the Gridiron Dinner in Washington, an annual event that brings together prominent government officials and journalists. At least 80 people who attended the dinner, the first since 2019, have tested positive for Covid including several senior government officials, according to Gridiron Club President Tom DeFrank.

    Attorney General Merrick Garland, Commerce Secretary Gina Raimondo, Reps. Joaquin Castro and Adam Schiff, and Sen. Susan Collins all tested positive after attending the dinner.
    House Speaker Nancy Pelosi, D- Calif., also tested positive for Covid last week but wasn’t experiencing any symptoms and didn’t attend the Gridiron Dinner. Pelosi’s positive result came a day after she stood next to President Joe Biden at a bill-signing ceremony. Biden, who also did not attend the Gridiron Dinner, subsequently tested negative for Covid.
    The outbreak among White House Cabinet officials and senior lawmakers comes as the rate of Covid infections in Washington has increased 73% in two weeks, though the overall level of transmission remains low compared with the winter surge. BA.2 represents 84% of new cases in the mid-Atlantic region that includes the nation’s capital.
    Philadelphia, meanwhile, became the first first major city in the U.S. to reinstate its indoor mask mandate effective April 18. The city made the decision after Covid cases rose more than 50% in 10 days, according to Dr. Cheryl Bettigole, Philadelphia’s health commissioner.
    Clarification: This story has been updated to reflect the most current data.

    WATCH LIVEWATCH IN THE APP More

  • in

    UBS expects 50,000 store closures in the U.S. over the next 5 years after pandemic pause

    While analysts at UBS see more pain ahead, it’s not as many closures as the investment bank had initially projected about a year ago.
    UBS is now projecting between 40,000 to 50,000 retail stores in the United States closing over the next five years, down from the 80,000 closures it previously forecasted.

    A shopper passes by a jewelry store that is going out of business in Brooklyn, New York, December 8, 2020.
    Brendan McDermid | Reuters

    A pandemic shakeup in 2020 led to a surge in store closures, coupled with dozens retailers filing for bankruptcy, which emptied out shopping malls and left vacancies scattered along the streets major markets including New York City.
    The aftermath, though, was a temporary relief from closures, as companies took the chance in 2020 to quickly slim down their store counts when consumers were holed up at home. In fact, in 2021, retailers reported net store openings, marking a sudden reversal from years of net declines. Companies seized the opportunity to take advantage of cheap rents and an eagerness among Americans to get out and shop again.

    While analysts at UBS see more pain ahead, it’s not as many closures as the investment bank had initially projected about a year ago.
    Brick-and-mortar shops have proven to serve a critical role for retailers’ businesses during the Covid pandemic, the bank said in a new report on Wednesday, and retail sales growth has remained strong, in part due to rising inflation. This all bodes well for the future of physical stores, according to UBS retail analyst Michael Lasser.
    UBS is now projecting between 40,000 to 50,000 retail stores in the United States closing over the next five years, down from the 80,000 closures it previously forecasted. That’s out of about 880,000 total retail stores that the firm tracks nationwide, excluding gas stations.
    This estimate assumes that U.S. retail sales grow about 4% annually, moving forward, and that e-commerce sales as a percentage of total retail sales grows to 25% by 2026, from 18% in 2021, Lasser said in the report.
    UBS sees the most closures shaking out among clothing and accessories retailers, consumer electronics businesses and home furnishing chains, or about 23,500 cumulatively within these categories by 2026.

    Traditional shopping malls remain at higher risk for closures than neighborhood strip centers, the firm said. That’s in large part because shopper traffic to malls, often anchored by department store chains, has been pressured in recent years as consumers favor quick trips to stores closer to where they live.
    Meanwhile, general merchandise retailers, such as Target and Walmart, and auto parts businesses are expected to report net openings in the years ahead.
    According to Lasser and his team, there is still about 58 square feet of shopping center space per household in the U.S., as of 2021. While that’s down from the 62 square feet per household in 2010, it’s above 55 square feet in 2000 and 49 square feet in 1990.
    As consumers shift more of their spending onto the web, it only makes sense that that number would shrink, Lasser explained.
    So far this year, retailers’ plans to open new locations are far outpacing their plans to shutter shops. Tracking data by Coresight Research show U.S. retailers having announced just 1,385 store closures, compared with a whopping 3,694 openings, as of April 1.
    The store growth is being driven by dollar chains and discount stores, like Dollar General and TJX – and also by a wave of so-called digitally native companies that started on the internet but are now seeking acquiring new customers via bricks and mortar. Some examples include Warby Parker, Allbirds, Vuori, Brooklinen and Fabletics.
    UBS, which releases these closely followed, deep-dive store closure reports every few years, said that the number of shopping centers in the U.S. reached a peak of 115,000 last year, up from 90,000 in 2000, despite a continued acceleration in e-commerce.

    WATCH LIVEWATCH IN THE APP More